We would particularly follow the launch of new products that enable Medtronic to position itself in new markets.
The Medtronic Group currently markets several product lines including pacemakers, defibrillators, stents, heart valves, neural stimulators, spinal disc replacements, insulin pumps, automated injectors and vascular and coronary prostheses. It is of course likely to develop new types of products in the coming years.